CoChat
Sign Up
Cited by 66

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Up-Regulation of miRNA-146a in Progressive, Age-Related Inflammatory Neurodegenerative Disorders of the Human CNS

Alexandrov, Peter N., Dua, Prerna, Lukiw, Walter J.·2014·Frontiers in Neurology
DOI 10.3389/fneur.2014.00181PMC PMC4179622
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2014.00181

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 44

  1. Cui, 2010, Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by miRNA-146a and NF-kB in stressed human astroglial cells and in Alzheimer disease, J Biol Chem, 285, 38951, 10.1074/jbc.M110.178848 · DOI · Paper page
  2. Lukiw, 2012, NF-kB-regulated micro RNAs (miRNAs) in primary human brain cells, Exp Neurol, 235, 484, 10.1016/j.expneurol.2011.11.022 · DOI · Paper page
  3. Li, 2011, Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells, Neurosci Lett, 499, 109, 10.1016/j.neulet.2011.05.044 · DOI · Paper page
  4. Pogue, 2009, Characterization of an NF-kB-regulated, miRNA-146a-mediated down-regulation of complement factor H in metal-sulfate-stressed human brain cells, J Inorg Biochem, 103, 1591, 10.1016/j.jinorgbio.2009.05.012 · DOI · Paper page
  5. Hill, 2009, HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling, Neuroreport, 20, 1500, 10.1097/WNR.0b013e3283329c05 · DOI · Paper page
  6. Mrak, 1997, Aging-associated changes in human brain, J Neuropathol Exp Neurol, 56, 1269, 10.1097/00005072-199712000-00001 · DOI
  7. Butterfield, 2002, Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer’s disease brain exists, J Alzheimers Dis, 4, 193, 10.3233/JAD-2002-4309 · DOI
  8. Kroesen, 2014, Immuno-miRs: critical regulators of T-cell development, function and ageing, Immunology, 10.1111/imm.12367 · DOI
  9. Zhao, 2014, Role of microRNA-146a in normal and malignant hematopoietic stem cell function, Front Genet, 5, 219, 10.3389/fgene.2014.00219 · DOI
  10. Sethi, 2009, Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex, Neurosci Lett, 459, 100, 10.1016/j.neulet.2009.04.052 · DOI · Paper page
  11. Taganov, 2006, NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci U S A, 103, 12481, 10.1073/pnas.0605298103 · DOI · Paper page
  12. Kutty, 2013, Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ, Mol Vis, 19, 737
  13. Colangelo, 2002, Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling, J Neurosci Res, 70, 462, 10.1002/jnr.10351 · DOI · Paper page
  14. Lukiw, 2004, Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling, Neurochem Res, 29, 1287, 10.1023/B:NERE.0000023615.89699.63 · DOI
  15. Ginsberg, 2012, Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer’s disease, Neurobiol Dis, 45, 99, 10.1016/j.nbd.2011.07.013 · DOI
  16. Kikuchi, 2013, Identification of unstable network modules reveals disease modules associated with the progression of Alzheimer’s disease, PLoS One, 8, e76162, 10.1371/journal.pone.0076162 · DOI
  17. Fu, 2014, Phagocytosis of microglia in the central nervous system diseases, Mol Neurobiol, 49, 1422, 10.1007/s12035-013-8620-6 · DOI
  18. Lukiw, 1992, BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD), Neurochem Res, 17, 591, 10.1007/BF00968788 · DOI
  19. Lukiw, 2007, Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus, Neuroreport, 18, 297, 10.1097/WNR.0b013e3280148e8b · DOI · Paper page
  20. Schipper, 2007, MicroRNA expression in Alzheimer blood mononuclear cells, Gene Regul Syst Bio, 1, 263
  21. Jiang, 2013, Identification of active transcription factor and miRNA regulatory pathways in Alzheimer’s disease, Bioinformatics, 29, 2596, 10.1093/bioinformatics/btt423 · DOI
  22. Lukiw, 2012, Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer’s disease (AD) brain, Mol Neurobiol, 46, 11, 10.1007/s12035-012-8234-4 · DOI · Paper page
  23. Zhao, 2013, Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer’s disease (AD) and in primary human neuronal-glial (HNG) cells, Mol Neurobiol, 10.1007/s12035-013-8595-3 · DOI
  24. Li, 2010, Gene expression variability within and between human populations and implications toward disease susceptibility, PLoS Comput Biol, 6, e1000910, 10.1371/journal.pcbi.1000910 · DOI
  25. Olson, 2012, Human genetic individuality, Annu Rev Genomics Hum Genet, 13, 1, 10.1146/annurev-genom-090711-163825 · DOI
  26. Lukiw, 2013, Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer’s disease (AD), Front Cell Neurosci, 7, 133, 10.3389/fncel.2013.00133 · DOI
  27. Khan, 2014, Present and possible therapies for age-related macular degeneration, ISRN Ophthalmol, 2014, 608390, 10.1155/2014/608390 · DOI
  28. Lukiw, 2012, Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer’s disease (AD) and in age-related macular degeneration (AMD), Int J Biochem Mol Biol, 3, 105
  29. Sivak, 2013, The aging eye: common degenerative mechanisms between the Alzheimer’s brain and retinal disease, Invest Ophthalmol Vis Sci, 54, 871, 10.1167/iovs.12-10827 · DOI
  30. Kaarniranta, 2011, Age-related macular degeneration (AMD): Alzheimer’s disease in the eye?, J Alzheimers Dis, 4, 615, 10.3233/JAD-2011-101908 · DOI · Paper page
  31. Lukiw, 2013, Studying microRNA function and dysfunction in Alzheimer’s disease, Front Genet, 3, 327, 10.3389/fgene.2012.00327 · DOI
  32. Donoso, 2010, The role of complement factor H (CFH) in age-related macular degeneration: a review, Surv Ophthalmol, 55, 227, 10.1016/j.survophthal.2009.11.001 · DOI
  33. Li, 2012, miRNA-155 upregulation and complement factor H deficits in Down’s syndrome, Neuroreport, 23, 168, 10.1097/WNR.0b013e32834f4eb4 · DOI
  34. Sjöberg, 2008, Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly, Mol Immunol, 45, 3213, 10.1016/j.molimm.2008.02.023 · DOI
  35. Fraser, 2014, Prions and prion-like proteins, J Biol Chem, 289, 19839, 10.1074/jbc.R114.583492 · DOI
  36. Saba, 2008, A miRNA signature of prion induced neurodegeneration, PLoS One, 3, e3652, 10.1371/journal.pone.0003652 · DOI · Paper page
  37. Lukiw, 2011, Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome, J Toxicol Environ Health A, 74, 1460, 10.1080/15287394.2011.618973 · DOI
  38. Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, 466, 835, 10.1038/nature09267 · DOI · Paper page
  39. Wang, 2010, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Res, 38, 7248, 10.1093/nar/gkq601 · DOI · Paper page
  40. Hill, 2014, miRNAs and viroids utilize common strategies in genetic signal transfer, Front Mol Neurosci, 7, 10, 10.3389/fnmol.2014.00010 · DOI
  41. Lukiw, 2012, Spreading of Alzheimer’s disease inflammatory signaling through soluble micro-RNA, Neuroreport, 23, 621, 10.1097/WNR.0b013e32835542b0 · DOI · Paper page
  42. Zhao, 2006, Natural secretory products of human neural and microvessel endothelial cells: implications in pathogenic “spreading” and Alzheimer’s disease, Mol Neurobiol, 34, 181, 10.1385/MN:34:3:181 · DOI
  43. Kumar, 2013, Circulating miRNA biomarkers for Alzheimer’s disease, PLoS One, 8, e69807, 10.1371/journal.pone.0069807 · DOI
  44. Alexandrov, 2012, microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF), Int J Biochem Mol Biol, 3, 365

Cited by

Sorted by citations

Metadata

Authors
Alexandrov, P. N., Dua, P., & Lukiw, W. J.
Venue
Frontiers in Neurology
Publisher
Frontiers Media SA
Published
2014-09-29
Volume
5
ISSN
1664-2295
DOI
10.3389/fneur.2014.00181
PMC
PMC4179622
Cited by
66
References
5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review